Can childhood cancer treatments affect survivors' sex lives in adulthood?

February 06, 2017

ö A recent analysis showed that although adult survivors of childhood cancer did not differ overall from their peers in terms of their satisfaction with their sex lives and romantic relationships, those who received cancer treatments that were especially toxic to the nervous system were least likely to have had intercourse, be in a relationship, or have children. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the report noted that even the groups of patients who reported achieving fewer such psychosexual milestones did not consistently report less satisfaction.

Cancer treatment during childhood can be detrimental to the developing brain and cause lasting neurocognitive impairments that can contribute to difficulties in social interactions. Therefore, due to their prior treatments, childhood cancer survivors may also face difficulties when trying to initiate sexual and romantic relationships in adulthood.

"Psychosexual development entails reaching certain milestones, such as sexual debut, entering committed relationships, or having children," said Vicky Lehmann, PhD, of Nationwide Children's Hospital and The Ohio State University, in Columbus. "It is a normative part of becoming an adolescent or young adult, but only comparing such milestones without taking satisfaction into account falls short. These issues are understudied among survivors of childhood cancer."

To investigate, Dr. Lehmann and her colleagues asked 144 young adult survivors of childhood cancer and 144 matched controls to complete questionnaires about psychosexual development, sexual satisfaction, and satisfaction with their relationship status. The researchers also used information from medical charts to rate the neurotoxicity of the treatment received.

Apart from having fewer lifetime sex partners, survivors did not differ from controls; however, subgroups such as survivors of brain tumors and any survivor who received high-dose neurotoxic treatments reported the lowest rates of achieving milestones of psychosexual development. Dr. Lehmann noted that although survivors who received high-dose neurotoxic treatments were less likely to reach certain milestones of psychosexual development, they were not necessarily less satisfied than others. "This highlights the subjective nature of psychosexual issues, and the importance of addressing any concerns in survivorship care."

The investigators have proposed a comprehensive and novel rating system for the neurotoxicity of childhood cancer treatment to detect those who are potentially at higher risk for impaired psychosexual outcomes. "This rating might be used as a checklist in clinical practice," said Dr. Lehmann.
-end-
Additional information:

Full Citation: "Psychosexual Development and Satisfaction in Long-Term Survivors of Childhood Cancer: Neurotoxic Treatment Intensity as a Risk Indicator." Vicky Lehmann, Marrit A. Tuinman, Madelaine C. Keim, Adrien M. Winning, Randal S. Olshefski, Rajinder P.S. Bajwa, Mariet Hagedoorn, and Cynthia A. Gerhardt. CANCER; Published Online: February 6, 2017 (DOI: 10.1002/cncr.30513).

URL Upon Publication: http://doi.wiley.com/10.1002/cncr.30513

Author Contact: Gina Bericchia in the media relations office at Nationwide Children's Hospital, at MediaRelations@NationwideChildrens.org or +1 (614) 355-0495.

About the Journal

CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online at http://wileyonlinelibrary.com/journal/cancer. Follow us on Twitter @JournalCancer and Facebook https://www.facebook.com/ACSJournals

About Wiley

Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 200 years, we have delivered consistent performance to our stakeholders.

Wiley

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.